Nestle is spending $2 billion to buy a company working to treat peanut allergies - Business Insider

Thomson ReutersNestle already owns a 25% stake in the company, which is working to develop peanut allergy treatments.

Nestle said on Monday its offer for Aimmune values the California-based drugmaker, in which it already has a stake of around 25.6%, at $2.6 billion.The U.S. company's shares have slumped this year, as the pandemic led to many clinician's offices remaining shut, leading to a slow launch of its therapy, Palforzia, which was approved in January.

"As pandemic-related disruption recedes and Palforzia's true demand begins to manifest, it will be deemed that Nestle got itself a bargain here," Raymond added. The deal helps Nestle, known for its KitKat chocolate bars and Nescafe instant coffee, expand its Nestle Health Science division which it set up in 2011 to open up a new area of business.

they'vr already bought Israeli OSEM, for much less...

how about coffee allergy.

2 billion? This is nuts!

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Aimmune soars 172% after Nestle agrees to acquire for $2.6 billion - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web. Do You Want To create 3d construction logo animation video ? Please Contact Me: LogoAnimation Construction logo animation Character Logo Animation top logo animation
Source: BusinessInsider - 🏆 729. / 51 Read more »

Business Insider's biggest advertising and media stories for August 31 - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web. Huge Data Harvesting Great proposition. Would love to see a real Amazon competitor. Whilst I don’t use Tik Tok, there’s no denying it’s monetisation potential.
Source: BusinessInsider - 🏆 729. / 51 Read more »